Table 6.
VDZ Trough Level | Entire Cohort | Active Disease | Remission |
---|---|---|---|
Switch n, median (IQR) |
n = 69, 16.9 (18.7) | n = 26, 19.6 (16) | n = 43, 14.9 (20) |
Week 8 n, median (IQR) |
n = 61, 33 (22.15) | n = 23, 32.4 (19.1) | n = 38, 34.25 (26.15) |
Week 20 n, median (IQR) |
n = 48, 31.7 (28.05) | n = 15, 28.1 (19.7) | n = 33, 33.9 (29.5) |
Vedolizumab (VDZ).